Literature DB >> 1878596

Regulation of human fetal and adult globin genes in mouse erythroleukemia cells.

B J Morley1, C A Abbott, W G Wood.   

Abstract

We have examined whether transfected mouse erythroleukaemia (MEL) cells can be used to examine differential expression of human gamma- and beta-globin genes. These cells, which express only their adult globin genes, will transcribe the human adult beta gene but not the fetal gamma genes when they are introduced on an intact human chromosome 11 by cell fusion. However, MEL cells stably transfected with the human A gamma gene attached to one of the active elements (HS2) of the beta-globin locus control region (LCR) readily produce gamma-globin mRNA in amounts equivalent to those seen with a comparable beta gene insert. When both beta and gamma genes are attached to HS2, equal amounts of beta A gamma mRNAs are produced, irrespective of the gene order. Furthermore, when HS2 is inserted into the 5' end of a 40-kb cosmid containing the G gamma A gamma-117 delta beta genes in their normal chromosomal organization (but with the Greek HPFH -117 A gamma gene mutation), it directs expression of readily detectable amounts of G gamma A gamma and beta-globin mRNAs in MEL cells. Therefore, under these circumstances we have observed no competition between beta and gamma genes for expression in MEL cells. These findings suggest that MEL cells are capable of perpetuating regulatory information involved in developmental control when it is provided by an intact chromosome, but are incapable of reconstructing such information on transfected DNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878596

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Identification of a conserved erythroid specific domain of histone acetylation across the alpha-globin gene cluster.

Authors:  E Anguita; C A Johnson; W G Wood; B M Turner; D R Higgs
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

2.  Induction of human fetal globin gene expression by a novel erythroid factor, NF-E4.

Authors:  W Zhou; D R Clouston; X Wang; L Cerruti; J M Cunningham; S M Jane
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  Use of yeast artificial chromosomes (YACs) for studying control of gene expression: correct regulation of the genes of a human beta-globin locus YAC following transfer to mouse erythroleukemia cell lines.

Authors:  K R Peterson; G Zitnik; C Huxley; C H Lowrey; A Gnirke; K A Leppig; T Papayannopoulou; G Stamatoyannopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

4.  Distinct domains of erythroid Krüppel-like factor modulate chromatin remodeling and transactivation at the endogenous beta-globin gene promoter.

Authors:  R Clark Brown; Scott Pattison; Janine van Ree; Elise Coghill; Andrew Perkins; Stephen M Jane; John M Cunningham
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice.

Authors:  Jeremy W Rupon; Shou Zhen Wang; Karin Gaensler; Joyce Lloyd; Gordon D Ginder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-11       Impact factor: 11.205

6.  Position independence and proper developmental control of gamma-globin gene expression require both a 5' locus control region and a downstream sequence element.

Authors:  Q Li; J A Stamatoyannopoulos
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

7.  Established epigenetic modifications determine the expression of developmentally regulated globin genes in somatic cell hybrids.

Authors:  S J Stanworth; N A Roberts; J A Sharpe; J A Sloane-Stanley; W G Wood
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

8.  Identification of a stage selector element in the human gamma-globin gene promoter that fosters preferential interaction with the 5' HS2 enhancer when in competition with the beta-promoter.

Authors:  S M Jane; P A Ney; E F Vanin; D L Gumucio; A W Nienhuis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.